Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT05607420 · RECRUITING

Trial details

NCT number: NCT05607420
Sponsor: Cellectis S.A.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Non-Hodgkin Lymphoma (B-NHL)

Start date: 2022-11-01
Primary completion: 2027-08-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.